학술논문
Decoupling of the PI3K pathway via mutation necessitates combinatorial treatment in HER2+ breast cancer
Document Type
article
Author
Source
Subject
Language
Abstract
© 2015 Korkola et al.We report here on experimental and theoretical efforts to determine how best to combine drugs that inhibit HER2 and AKT in HER2+ breast cancers. We accomplished this by measuring cellular and molecular responses to lapatinib